Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia 20Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Lymphoma 11Lymphoma, Non-Hodgkin 9Lymphoma, Large B-Cell, Diffuse 9Burkitt Lymphoma 9Myelodysplastic Syndromes 8Lymphoma, Follicular 8Leukemia, Lymphocytic, Chronic, B-Cell 8Multiple Myeloma 7Leukemia, Myeloid, Chronic-Phase 7Leukemia, Myeloid, Acute 7Lymphoma, Mantle-Cell 6Lymphoma, B-Cell, Marginal Zone 6Hodgkin Disease 6Blast Crisis 6Recurrence 5Neoplasms, Plasma Cell 5Leukemia, Myeloid, Accelerated Phase 5Graft vs Host Disease 5Dendritic Cell Sarcoma, Interdigitating 5Congenital Abnormalities 5Myeloproliferative Disorders 4Lymphoma, Large-Cell, Immunoblastic 4Leukemia, Myelomonocytic, Juvenile 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, B-Cell 3Leukemia, Myelomonocytic, Chronic 3Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3Hematologic Neoplasms 3

Interventions

Radiotherapy 2Pyridoxine 2Etoposide 2Cytarabine 2Cyclophosphamide 2sodium thiosulfate 1pegfilgrastim 1pegaspargase 1etoposide phosphate 1Vincristine 1Triptorelin Pamoate 1Rituximab 1Prednisolone 1Methylprednisolone 1Methotrexate 1Mercaptopurine 1Leucovorin 1Hydrocortisone 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Doxorubicin 1Dexrazoxane 1Dexamethasone 1Celecoxib 1Carboplatin 1Capecitabine 1Asparaginase 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Drug-Related Side Effects and Adverse Reactions × Methylprednisolone × Clear all
NCT00400946 2026-02-13

05-001: Treatment of Acute Lymphoblastic Leukemia in Children

Dana-Farber Cancer Institute

Phase 3 Completed
800 enrolled 22 charts
LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡